The Contrast Media Injectors Market is expected to be sold this year, 2023, is estimated to be around US$ 1.6 billion. Furthermore, the global contrast media injector market is expected to reach approximately US$ 3 billion by 2033, with a 6.6% annual growth rate.
Increasing trauma cases globally is expected to boost the growth of the contrast media injectors market. Additionally, the increasing prevalence of cancer among the geriatric population globally is expected to drive demand for the contrast media injectors market.
Take the first step towards enhanced performance and unmatched efficiency today! Request Sample Now :
https://www.futuremarketinsights.com/reports/sample/rep-gb-823
Furthermore, as the number of cancer, neurological, and cardiovascular patients admitted to hospitals rises, the industry will experience significant growth. With the vast range of applications in radiology, interventional radiology, and interventional cardiology, hospitals are the principal users of high-pressure contrast media injectors.
End-user demand for technologically improved contrast media injectors, such as IT-enabled contrast media injectors that can connect to a hospital database for dosage monitoring, is driving up contrast media injector prices.
Air emboli formed during contrast media injection can restrict right ventricular outflow or clog pulmonary arterioles, resulting in significant complications such as cardiovascular collapse.
Radiographic contrast injectors are medical devices that are used to inject contrast media into a patient’s body for medical imaging procedures such as CT scans, MRI scans, and angiography. Contrast media is a substance that helps enhance the visibility of certain organs or tissues during these procedures.
Key Takeaways from the Contrast Media Injectors Market Study Report
The United States is the leading market with a market share of 32.5%, which is around US$ 500 Million in 2023. The demand for contrast media injectors in the country is projected to grow at a rate of 6.8% from 2023 to 2033.
In Europe, Germany is the dominant market and is projected to register a CAGR of 6.3% from 2023 to 2033. It is the second-largest market in the world and is predicted to reach US$ 202.9 Million by the end of 2033.
While. the demand for contrast media injectors in the United Kingdom is growing faster than in Germany. The report predicts the growth rate for the UK market to be 6.4% through 2033 to reach a valuation of US$ 123.3 Million.
Meanwhile, China is the fastest-growing region in the production and sales of contrast media injectors around the world. By registering a CAGR of 7.8% over the forecast years, this regional market is estimated to reach US$ 192.3 Million by 2033.
India is emerging as a promising market with growing demand for contrast media injectors. The growth rate estimated for this regional market is around 5.4%, and the net worth of the market is to reach US$ 42.5 Million by 2033.
Among the different types of contrast media injectors available in the market, CT injectors are the top-performing product type segment. This segment is projected to grow at a rate of 6.4% during the time period covering 2023 to 2033.
For the contrast media injectors market players, the hospital segment is predicted to remain the prominent end-user vertical. During the forecast period, this segment is expected to witness a year-on-year growth rate of 6.7% from 2023 to 2033.
Competitive Landscape for the Contrast Media Injectors Market
- Mallinckrodt (Guerbet SA)
- GE Healthcare
- Bayer AG
- Ulrich GmbH & Co. KG
- Bracco Imaging S.p.A
- Medtron
- NemotoKyorindo Co. Ltd
- Shenzhen Anke High-tech Co. Ltd
- Sino Medical-device Technology Co., Ltd
- Apollo RT Co., Ltd
Unlock a wealth of knowledge with our methodology insights now:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-823
Recent Developments in the Contrast Media Injectors Industry
- In May 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of therapy-accompanying diagnostic tests – also known as companion diagnostics (CDx) – for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
- In May 2019, the Ulrich’s CT contrast agent injector, CT motion, was made available in the world’s most important medical technology market, the U.S.
Contrast Media Injectors Market by Category
By Product Type:
- CT Injectors
- MRI Injectors
- Cardio Injectors
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostics Centers
- Others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube